TANG CAPITAL MANAGEMENT LLC
Filing Date
Global Rank
#1,221
/ 8,605
▲ 36
· as of Mar 2026
Top Industry
Biotechnology
89.0%
3Y Alpha vs SPY
+3.9%
Period ended 3 months ago
Filed May 15, 2026 · 55d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+57.6%
SPY
+76.5%
Annualised alpha
-4.5%
Max drawdown
−42.7%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
50 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
9.3%
−0.2 pts
Top 5
32.8%
−0.0 pts
Top 10
58.7%
+2.4 pts
HHI
463
Diversified+59
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 94.4% | $1,834,244,201 |
| Unclassified | 5.6% | $109,257,120 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
9 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CAPR | Capricor Therapeutics, Inc. | +1,699,900 | 3,399,900 | $103,356,960 | |
| CORT | Corcept Therapeutics Inc | +1,343,236 | 1,500,000 | $60,465,000 | |
| AUPH | Aurinia Pharmaceuticals Inc. | +900,000 | 12,229,500 | $181,241,190 | |
| PGEN | Precigen, Inc. | +800,000 | 6,417,500 | $24,835,725 | |
| CBIO | Crescent Biopharma, Inc. | +287,602 | 1,160,000 | $21,309,200 | |
| ANIP | Ani Pharmaceuticals Inc | +226,063 | 707,500 | $54,406,750 | |
| INSM | INSMED Inc | +200,000 | 260,000 | $42,515,200 | |
| SPY | Spdr S&P 500 ETF Trust | +138,000 | 168,000 | $109,257,120 | |
| IMCR | Immunocore Holdings plc | +20,830 | 2,649,368 | $79,878,445 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
13 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ALT | Altimmune, Inc. | −1,465,285 | 666,022 | $2,051,347 | |
| CHRS | Coherus Oncology, Inc. | −837,761 | 1,886,748 | $3,188,604 | |
| EOLS | Evolus, Inc. | −762,671 | 483,021 | $1,985,216 | |
| NUVB | Nuvation Bio Inc. | −707,900 | 3,149,557 | $13,511,599 | |
| ERAS | Erasca, Inc. | −700,000 | 200,000 | $3,236,000 | |
| PMVP | PMV Pharmaceuticals, Inc. | −694,915 | 4,245,085 | $5,263,905 | |
| ABEO | Abeona Therapeutics Inc. | −600,000 | 400,000 | $1,792,000 | |
| MRNA | Moderna, Inc. | −592,820 | 100,000 | $5,080,000 | |
| LENZ | LENZ Therapeutics, Inc. | −414,055 | 451,114 | $4,127,693 | |
| DERM | Journey Medical Corp | −244,596 | 1,610,000 | $7,550,900 | |
| LKFT | Lakefront Biotherapeutics NV | −135,228 | 3,785,991 | $113,579,730 | |
| ARVN | Arvinas, Inc. | −31,040 | 538,658 | $5,709,774 | |
| ANAB | Anaptysbio, Inc | −1,208 | 1,330,879 | $49,206,988 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
4 positions
Sold Out
Positions the filer fully exited
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc / Ma | 80,000 | $36,268,800 | |
| TVTX | Travere Therapeutics, Inc. | 700,000 | $26,747,000 | |
| NVDA | Nvidia Corp | 127,788 | $23,832,462 | |
| META | Meta Platforms, Inc. | 23,331 | $15,400,559 | |
| GSK | GSK plc | 300,000 | $14,712,000 | |
| PCVX | Vaxcyte, Inc. | 275,000 | $12,688,500 | |
| HRMY | Harmony Biosciences Holdings, Inc. | 290,292 | $10,862,726 | |
| BMY | Bristol Myers Squibb Co | 200,000 | $10,788,000 | |
| TDOC | Teladoc Health, Inc. | 1,400,000 | $9,800,000 | |
| VSTM | Verastem, Inc. | 1,069,810 | $8,258,933 | |
| ACAD | Acadia Pharmaceuticals Inc | 300,000 | $8,013,000 | |
| SRPT | Sarepta Therapeutics, Inc. | 349,220 | $7,515,214 | |
| TBPH | Theravance Biopharma, Inc. | 351,252 | $6,571,924 | |
| BCRX | Biocryst Pharmaceuticals Inc | 800,000 | $6,240,000 | |
| REGN | Regeneron Pharmaceuticals, Inc. | 8,000 | $6,174,960 | |
| IBRX | ImmunityBio, Inc. | 2,333,333 | $4,619,999 | |
| NUVL | Nuvalent, Inc. | 21,880 | $2,200,909 | |
| ARE | Alexandria Real Estate Equities, Inc. | 40,000 | $1,957,600 | |
| STRO | Sutro Biopharma, Inc. | 139,617 | $1,615,368 | |
| BHVN | Biohaven Ltd. | 140,000 | $1,580,600 | |
| RVMD | Revolution Medicines, Inc. | 15,640 | $1,245,726 | |
| ZYME | Zymeworks Inc. | 34,631 | $911,834 | |
| ACET | Adicet Bio, Inc. | 6,158 | $51,850 | |
| TCRX | TScan Therapeutics, Inc. | 46,131 | $46,131 | |
| FLNA | Filana Therapeutics, Inc. | 7,073 | $14,004 | |
| No positions match the current search. | ||||
50 positions ·
$1,943,501,321 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| AUPH |
Aurinia Pharmaceuticals Inc.
Healthcare
|
Added | 12,229,500 | $181,241,190 | 9.33% | |
| CELC |
Celcuity Inc.
Healthcare
|
Held | 1,050,000 | $119,847,000 | 6.17% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Held | 1,236,027 | $114,184,174 | 5.88% | |
| LKFT |
Lakefront Biotherapeutics NV
Healthcare
|
Reduced | 3,785,991 | $113,579,730 | 5.84% | |
| SPY |
Spdr S&P 500 ETF Trust
|
Added | 168,000 | $109,257,120 | 5.62% | |
| KNSA |
Kiniksa Pharmaceuticals International, plc
Healthcare
|
Held | 2,259,889 | $108,813,655 | 5.60% | |
| CAPR |
Capricor Therapeutics, Inc.
Healthcare
|
Added | 3,399,900 | $103,356,960 | 5.32% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
Held | 1,500,000 | $102,195,000 | 5.26% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Reduced | 1,892,200 | $95,442,568 | 4.91% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
Held | 4,573,530 | $92,065,158 | 4.74% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Held | 16,790,809 | $88,823,379 | 4.57% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Held | 1,188,624 | $83,381,973 | 4.29% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
Added | 2,649,368 | $79,878,445 | 4.11% | |
| CORT |
Corcept Therapeutics Inc
Healthcare
|
Added | 1,500,000 | $60,465,000 | 3.11% | |
| ANIP |
Ani Pharmaceuticals Inc
Healthcare
|
Added | 707,500 | $54,406,750 | 2.80% | |
| ANAB |
Anaptysbio, Inc
Healthcare
|
Reduced | 1,330,879 | $49,206,988 | 2.53% | |
| INSM |
INSMED Inc
Healthcare
|
Added | 260,000 | $42,515,200 | 2.19% | |
| BNTX |
BioNTech SE
Healthcare
|
Held | 470,000 | $41,773,600 | 2.15% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
Held | 1,792,626 | $35,063,764 | 1.80% | |
| AVIR |
Atea Pharmaceuticals, Inc.
Healthcare
|
Held | 4,814,700 | $25,903,086 | 1.33% | |
| PGEN |
Precigen, Inc.
Healthcare
|
Added | 6,417,500 | $24,835,725 | 1.28% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Held | 264,692 | $22,212,952 | 1.14% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
NEW | 4,002,200 | $22,132,166 | 1.14% | |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
Added | 1,160,000 | $21,309,200 | 1.10% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
Held | 500,000 | $16,280,000 | 0.84% | |
| VKTX |
Viking Therapeutics, Inc.
Healthcare
|
Held | 500,000 | $16,270,000 | 0.84% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Held | 450,000 | $14,994,000 | 0.77% | |
| NUVB |
Nuvation Bio Inc.
Healthcare
|
Reduced | 3,149,557 | $13,511,599 | 0.70% | |
| PLRX |
Pliant Therapeutics, Inc.
Healthcare
|
Held | 6,143,132 | $7,740,346 | 0.40% | |
| DERM |
Journey Medical Corp
Healthcare
|
Reduced | 1,610,000 | $7,550,900 | 0.39% | |
| JANX |
Janux Therapeutics, Inc.
Healthcare
|
NEW | 500,000 | $6,950,000 | 0.36% | |
| BIIB |
Biogen Inc.
Healthcare
|
Held | 35,000 | $6,416,550 | 0.33% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
Held | 350,000 | $6,293,000 | 0.32% | |
| ARVN |
Arvinas, Inc.
Healthcare
|
Reduced | 538,658 | $5,709,774 | 0.29% | |
| PMVP |
PMV Pharmaceuticals, Inc.
Healthcare
|
Reduced | 4,245,085 | $5,263,905 | 0.27% | |
| MRNA |
Moderna, Inc.
Healthcare
|
Reduced | 100,000 | $5,080,000 | 0.26% | |
| HRTX |
Heron Therapeutics, Inc. /De/
Healthcare
|
Held | 6,250,000 | $5,000,000 | 0.26% | |
| KZR |
Kezar Life Sciences, Inc.
Healthcare
|
Held | 664,314 | $4,929,209 | 0.25% | |
| WVE |
Wave Life Sciences Ltd.
Healthcare
|
Held | 600,000 | $4,350,000 | 0.22% | |
| LENZ |
LENZ Therapeutics, Inc.
Healthcare
|
Reduced | 451,114 | $4,127,693 | 0.21% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
NEW | 100,000 | $3,383,000 | 0.17% | |
| ERAS |
Erasca, Inc.
Healthcare
|
Reduced | 200,000 | $3,236,000 | 0.17% | |
| CHRS |
Coherus Oncology, Inc.
Healthcare
|
Reduced | 1,886,748 | $3,188,604 | 0.16% | |
| NKTX |
Nkarta, Inc.
Healthcare
|
Held | 1,480,823 | $3,124,536 | 0.16% | |
| ALT |
Altimmune, Inc.
Healthcare
|
Reduced | 666,022 | $2,051,347 | 0.11% | |
| EOLS |
Evolus, Inc.
Healthcare
|
Reduced | 483,021 | $1,985,216 | 0.10% | |
| ABEO |
Abeona Therapeutics Inc.
Healthcare
|
Reduced | 400,000 | $1,792,000 | 0.09% | |
| FATE |
Fate Therapeutics Inc
Healthcare
|
Held | 1,167,773 | $1,401,327 | 0.07% | |
| LXRX |
Lexicon Pharmaceuticals, Inc.
Healthcare
|
NEW | 399,700 | $623,532 | 0.03% | |
| RCKT |
Rocket Pharmaceuticals, Inc.
Healthcare
|
Held | 100,000 | $358,000 | 0.02% |